Q2 2020

Filed Aug 10, 2020 · 10-Q · 41 days after period end · 0000877860-20-000091

Q2 2020 · 10-Q

Revenue

$84.17M

+7.8% vs Q2 2019

Net Income

$44.37M

+11.0% vs Q2 2019

EPS Diluted

$0.99

+7.6% vs Q2 2019

Margins · derived

Net margin52.7%+1.5 pt vs Q2 2019

Same quarter

Metric	Q2 2020	Q2 2019	Q2 2018	Q2 2017
Revenue	$84.17M	$78.10M	$72.96M	$69.84M
Net Income	$44.37M	$39.98M	$37.84M	$38.25M
EPS Diluted	$0.99	$0.92	$0.91	$0.93

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

National Health Investors Inc · CIK 877860 · Engraved from SEC EDGAR